Global and Local Determinants for the Kinetics of Interleukin‐4/Interleukin‐4 Receptor α Chain Interaction

An engineered interleukin-4-binding protein (IL4-BP) representing the extracellular domain of the human interleukin-4 (IL-4) receptor α chain was expressed in Sf9 cells. The purified IL4-BP was immobilized via a single biotinylated SH group near the carboxyl end to a biosensor matrix and analysed in real time for interaction with IL-4 and IL-4 variants. IL-4 was bound to IL4-BP at a molar ratio of approximately 1:1. The association and dissociation at pH 7.4 and 150 mM NaCl had rate constants of 1.9 ± 0.3 × 107 M−1 s−1 and 2 ± 1 × 10−3 s−1, respectively. Glycosylation and engineered amino acid substitutions of IL4-BP did not alter the kinetic constants as shown by a parallel analysis of IL4-BP variants produced in Escherichia coli or Chinese hamster ovary cells. The rate of association was only slighly affected in binding-deficient variants [E9QJIL-4 and [R88Q]IL-4 and by acidic pH down to values of 4.5, but it was reduced up to fivefold at higher ionic strength. The rate of dissociation was increased 70-fold and 150-fold with the IL-4 variants and fivefold at an acidic pH of 4.5, but it was not affected by high ionic strength. Temperatures between 6°C and 37°C yielded similar rates of IL-4 dissociation and only a marginally reduced rate of IL-4 association at 6°C. These results indicate that the high-affinity binding of IL-4 to its receptor (Kd≈100 pM) is mainly the result of an unusually high association rate. The IL-4/IL4-BP interaction appears to be dominated by charge effects. The exceedingly high rate of IL–4/IL4-BP association is augmented by the overall electrostatic potentials of both proteins (electrostatic steering). Localized charges and the formation of ion pairs may control the rate of complex dissociation.

[1]  P. Bamborough,et al.  The interleukin-2 and interleukin-4 receptors studied by molecular modelling. , 1995, Structure.

[2]  J. Wells,et al.  Comparison of a structural and a functional epitope. , 1993, Journal of molecular biology.

[3]  D. S. Garrett,et al.  The high-resolution, three-dimensional solution structure of human interleukin-4 determined by multidimensional heteronuclear magnetic resonance spectroscopy. , 1993, Biochemistry.

[4]  H. Erickson,et al.  Kinetics of protein-protein association explained by Brownian dynamics computer simulation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[5]  H Oschkinat,et al.  Receptor binding properties of four‐helix‐bundle growth factors deduced from electrostatic analysis , 1994, Protein science : a publication of the Protein Society.

[6]  G Schreiber,et al.  Interaction of barnase with its polypeptide inhibitor barstar studied by protein engineering. , 1993, Biochemistry.

[7]  W. Sebald,et al.  Mutant proteins of human interleukin 2. Renaturation yield, proliferative activity and receptor binding. , 1989, European journal of biochemistry.

[8]  W. Sebald,et al.  Two distinct functional sites of human interleukin 4 are identified by variants impaired in either receptor binding or receptor activation. , 1993, The EMBO journal.

[9]  A. Wlodawer,et al.  A model of the complex between interleukin‐4 and its receptors , 1995, Proteins.

[10]  S E Ealick,et al.  Crystal structure of recombinant human interleukin-4. , 1994, The Journal of biological chemistry.

[11]  D. O'Shannessy,et al.  Determination of kinetic rate and equilibrium binding constants for macromolecular interactions: a critique of the surface plasmon resonance literature. , 1994, Current opinion in biotechnology.

[12]  J A Wells,et al.  Binding in the growth hormone receptor complex. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[13]  C. Benoist,et al.  Transformation of mouse fibroblasts to methotrexate resistance by a recombinant plasmid expressing a prokaryotic dihydrofolate reductase. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. Bazan,et al.  Structural design and molecular evolution of a cytokine receptor superfamily. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[15]  V. Jäger,et al.  Biosynthesis and secretion of human interleukin 2 glycoprotein variants from baculovirus-infected Sf21 cells. Characterization of polypeptides and posttranslational modifications. , 1993, European journal of biochemistry.

[16]  S. Bass,et al.  The human growth hormone receptor. Secretion from Escherichia coli and disulfide bonding pattern of the extracellular binding domain. , 1990, The Journal of biological chemistry.

[17]  B. Pramanik,et al.  Characterization of recombinant human interleukin 4 receptor from CHO cells: role of N-linked oligosaccharides. , 1995, Biochemical and biophysical research communications.

[18]  M. Ultsch,et al.  Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. , 1992, Science.

[19]  I. Brooks,et al.  Determination of rate and equilibrium binding constants for macromolecular interactions by surface plasmon resonance. , 1994, Methods in enzymology.

[20]  W. Sebald,et al.  Aspects of receptor binding and signalling of interleukin-4 investigated by site-directed mutagenesis and NMR spectroscopy. , 1994, Journal of molecular biology.

[21]  W. Sebald,et al.  Transmembrane and intracellular signalling by interleukin-4: receptor dimerization and beyond. , 1996, European cytokine network.

[22]  A. Wlodawer,et al.  Direct evidence of a heterotrimeric complex of human interleukin‐4 with its receptors , 1995 .

[23]  C. Pace,et al.  How to measure and predict the molar absorption coefficient of a protein , 1995, Protein science : a publication of the Protein Society.

[24]  A. Wlodawer,et al.  Stoichiometry of the complex of human interleukin‐4 with its receptor , 1994, FEBS letters.

[25]  J. Banchereau,et al.  Internalization of human interleukin 4 and transient down-regulation of its receptor in the CD23-inducible Jijoye cells. , 1989, The Journal of biological chemistry.

[26]  G Schreiber,et al.  Energetics of protein-protein interactions: analysis of the barnase-barstar interface by single mutations and double mutant cycles. , 1995, Journal of molecular biology.

[27]  A. Gustchina,et al.  Crystal structure of human recombinant interleukin‐4 at 2.25 Å resolution , 1992, FEBS letters.

[28]  W. Sebald,et al.  Conversion of human interleukin‐4 into a high affinity antagonist by a single amino acid replacement. , 1992, The EMBO journal.

[29]  S. Liang,et al.  Regulation by glutathione of interleukin-4 activity on cytotoxic T cells. , 1992, Immunology.

[30]  R A Smith,et al.  Human interleukin 4. The solution structure of a four-helix bundle protein. , 1992, Journal of molecular biology.

[31]  J. Banchereau,et al.  Molecular cloning of a cDNA encoding the human interleukin 4 receptor. , 1990, International immunology.

[32]  I. Lax,et al.  Real-time measurements of kinetics of EGF binding to soluble EGF receptor monomers and dimers support the dimerization model for receptor activation. , 1993, Biochemistry.

[33]  C. Heldin,et al.  Dimerization of cell surface receptors in signal transduction , 1995, Cell.

[34]  L. Sullivan,et al.  Immunochemical mapping of domains in human interleukin 4 recognized by neutralizing monoclonal antibodies. , 1993, Biochemistry.

[35]  C. Maliszewski,et al.  The interleukin-4 receptor: structure, function, and signal transduction. , 1992, Chemical immunology.

[36]  C. March,et al.  Human interleukin 4 receptor confers biological responsiveness and defines a novel receptor superfamily , 1990, The Journal of experimental medicine.

[37]  M. Buehner,et al.  Human interleukin-4 and variant R88Q: phasing X-ray diffraction data by molecular replacement using X-ray and nuclear magnetic resonance models. , 1995, Journal of molecular biology.

[38]  S. Moseley,et al.  Characterization of the gene encoding heat-stable toxin II and preliminary molecular epidemiological studies of enterotoxigenic Escherichia coli heat-stable toxin II producers , 1983, Infection and immunity.

[39]  S. Ziegler,et al.  Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor. , 1993, Science.

[40]  K. Arai,et al.  Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4. , 1993, Science.